Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Aquiline Capital Partners takes majority stake in BI-SAM

Tuesday, July 10, 2012
Opalesque Industry Update: – Aquiline Capital Partners LLC (“Aquiline”), a New York-based private equity firm investing in financial services, today announced that it has become the majority shareholder of BI-SAM Technologies (“BI-SAM”), the leading provider of data management, performance, ® attribution, risk, GIPS and reporting solutions for the asset management industry. BI-SAM was founded in 2000 by Alexandre Harkous, Christophe Volard and Xavier Chaude, experts in ® asset management and analytics technology. Over the next 12 years, the team built BI-SAM’s B-One platform into the market leader, serving Tier I asset managers across Europe, North America and Asia.

As the majority owner, Aquiline will provide financial and operational support, including North American presence and expertise, to aid BI-SAM in its plan for growth and expansion. BI-SAM intends to increase its market share across all tiers of the global asset management industry.

BI-SAM will continue its strategy of global expansion and bolster its client services and implementation partnerships. BI-SAM plans to increase materially the size of its workforce over the next three years, most notably in North America and the Asia-Pacific region, to further its growth and operations in those geographies.

“BI-SAM’s success is a reflection of the quality of our team and our B-One platform. This platform has enabled asset managers all over the world to adapt to evolving regulation, reduce risk and operational costs, measure and analyze portfolio performance, and enhance their client communication,” said Alexandre Harkous, CEO of BI-SAM. “With Aquiline’s support, we now have the proper resources to drive our strategic plan forward and to grow both organically and through acquisition while delivering the best solutions and services to our customers.”

“We chose to invest in BI-SAM in partnership with the management team because of its strong competitive position, high growth potential, and its clear vision for the future,” said Jeff Greenberg, Chief Executive of Aquiline. “BI-SAM’s unique, full-service offering allows asset managers to improve their operations and better service investors by increasing their efficiency and transparency, and we look forward to supporting the continued growth and expansion of the business.”

Terms of the transaction were not disclosed.

Aquiline

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for